Search

Nancy V Le

Director (ID: 14886, Phone: (571)272-4056 , Office: P/2400 )

Most Active Art Unit
2108
Art Unit(s)
2108, 2861, 2858, 2853, 2107
Total Applications
431
Issued Applications
255
Pending Applications
24
Abandoned Applications
152

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7034377 [patent_doc_number] => 20050032887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Novel lactone compound' [patent_app_type] => utility [patent_app_number] => 10/866600 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5318 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032887.pdf [firstpage_image] =>[orig_patent_app_number] => 10866600 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/866600
Lactone compound Jun 9, 2004 Issued
Array ( [id] => 7605323 [patent_doc_number] => 07115606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Method of treating lower urinary tract disorders' [patent_app_type] => utility [patent_app_number] => 10/863770 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28704 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115606.pdf [firstpage_image] =>[orig_patent_app_number] => 10863770 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/863770
Method of treating lower urinary tract disorders Jun 6, 2004 Issued
Array ( [id] => 7265368 [patent_doc_number] => 20040242904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent' [patent_app_type] => new [patent_app_number] => 10/497370 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6234 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242904.pdf [firstpage_image] =>[orig_patent_app_number] => 10497370 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/497370
Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent Jun 2, 2004 Abandoned
10/858554 Antitumor compositions containing taxane derivatives Jun 1, 2004 Abandoned
Array ( [id] => 7378078 [patent_doc_number] => 20040220158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => '5-Androsten-3beta-ol steroid intermediates and processes for their preparation' [patent_app_type] => new [patent_app_number] => 10/858177 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9470 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220158.pdf [firstpage_image] =>[orig_patent_app_number] => 10858177 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858177
5-androsten-3β-ol steroid intermediates and processes for their preparation May 31, 2004 Issued
Array ( [id] => 7117298 [patent_doc_number] => 20050070599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide' [patent_app_type] => utility [patent_app_number] => 10/853834 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5872 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070599.pdf [firstpage_image] =>[orig_patent_app_number] => 10853834 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/853834
Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide May 25, 2004 Abandoned
Array ( [id] => 928633 [patent_doc_number] => 07314943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Pyran derivatives containing an exocyclic double bond' [patent_app_type] => utility [patent_app_number] => 10/852731 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26196 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314943.pdf [firstpage_image] =>[orig_patent_app_number] => 10852731 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852731
Pyran derivatives containing an exocyclic double bond May 24, 2004 Issued
Array ( [id] => 7616885 [patent_doc_number] => 06946556 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-20 [patent_title] => 'Preparation of opioid analgesics by a one-pot process' [patent_app_type] => utility [patent_app_number] => 10/851528 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2550 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946556.pdf [firstpage_image] =>[orig_patent_app_number] => 10851528 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851528
Preparation of opioid analgesics by a one-pot process May 20, 2004 Issued
Array ( [id] => 7276401 [patent_doc_number] => 20040235852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Benzofuran inhibitors of factor VIIa' [patent_app_type] => new [patent_app_number] => 10/850231 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22636 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235852.pdf [firstpage_image] =>[orig_patent_app_number] => 10850231 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/850231
Benzofuran inhibitors of factor VIIa May 18, 2004 Issued
Array ( [id] => 448924 [patent_doc_number] => 07250447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Acylsulfamide inhibitors of factor VIIa' [patent_app_type] => utility [patent_app_number] => 10/850312 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18791 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250447.pdf [firstpage_image] =>[orig_patent_app_number] => 10850312 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/850312
Acylsulfamide inhibitors of factor VIIa May 18, 2004 Issued
Array ( [id] => 7427224 [patent_doc_number] => 20040229864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Sulfone derivatives as 5-HT7 receptor ligands' [patent_app_type] => new [patent_app_number] => 10/845847 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27496 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229864.pdf [firstpage_image] =>[orig_patent_app_number] => 10845847 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845847
Sulfone derivatives as 5-HT7 receptor ligands May 13, 2004 Issued
Array ( [id] => 7432502 [patent_doc_number] => 20040209825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto' [patent_app_type] => new [patent_app_number] => 10/838766 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9995 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209825.pdf [firstpage_image] =>[orig_patent_app_number] => 10838766 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/838766
Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto May 3, 2004 Abandoned
Array ( [id] => 7319273 [patent_doc_number] => 20040224994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives' [patent_app_type] => new [patent_app_number] => 10/832624 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17396 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224994.pdf [firstpage_image] =>[orig_patent_app_number] => 10832624 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/832624
Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives Apr 26, 2004 Issued
Array ( [id] => 1028134 [patent_doc_number] => 06881851 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-19 [patent_title] => 'Preparation of tetrahydro-3-furoic acid' [patent_app_type] => utility [patent_app_number] => 10/828728 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2258 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/881/06881851.pdf [firstpage_image] =>[orig_patent_app_number] => 10828728 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828728
Preparation of tetrahydro-3-furoic acid Apr 20, 2004 Issued
Array ( [id] => 956373 [patent_doc_number] => 06956124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-18 [patent_title] => 'Process for the preparation of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-19-norcyclopropa[g]tax-11-ene' [patent_app_type] => utility [patent_app_number] => 10/824030 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2926 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/956/06956124.pdf [firstpage_image] =>[orig_patent_app_number] => 10824030 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/824030
Process for the preparation of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-19-norcyclopropa[g]tax-11-ene Apr 13, 2004 Issued
Array ( [id] => 616600 [patent_doc_number] => 07145012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Cannabinoid receptor ligands and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/823107 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26791 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/145/07145012.pdf [firstpage_image] =>[orig_patent_app_number] => 10823107 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/823107
Cannabinoid receptor ligands and uses thereof Apr 11, 2004 Issued
Array ( [id] => 620252 [patent_doc_number] => 07141669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-28 [patent_title] => 'Cannabiniod receptor ligands and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/822988 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25336 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141669.pdf [firstpage_image] =>[orig_patent_app_number] => 10822988 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/822988
Cannabiniod receptor ligands and uses thereof Apr 11, 2004 Issued
Array ( [id] => 7378991 [patent_doc_number] => 20040220258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Materials and methods for treating coagulation disorders' [patent_app_type] => new [patent_app_number] => 10/822129 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7546 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220258.pdf [firstpage_image] =>[orig_patent_app_number] => 10822129 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/822129
Materials and methods for treating coagulation disorders Apr 7, 2004 Issued
Array ( [id] => 7378987 [patent_doc_number] => 20040220257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Mitochrondrial permeability transition pore affinity labels and modulators' [patent_app_type] => new [patent_app_number] => 10/817975 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10525 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220257.pdf [firstpage_image] =>[orig_patent_app_number] => 10817975 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/817975
Mitochrondrial permeability transition pore affinity labels and modulators Apr 4, 2004 Issued
Array ( [id] => 7466764 [patent_doc_number] => 20040198759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Aporphine and oxoaporphine compounds and pharmaceutical use thereof' [patent_app_type] => new [patent_app_number] => 10/817641 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9309 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198759.pdf [firstpage_image] =>[orig_patent_app_number] => 10817641 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/817641
Aporphine and oxoaporphine compounds and pharmaceutical use thereof Apr 1, 2004 Issued
Menu